These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis. Coles GA; Alobaidi HM; Topley N; Davies M Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114 [TBL] [Abstract][Full Text] [Related]
9. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis. Clark LA; Easmon CS J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis? de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329 [TBL] [Abstract][Full Text] [Related]
11. Biomaterial-associated staphylococcal peritoneal infections in a neutropaenic mouse model. Rozalska B; Ljungh A FEMS Immunol Med Microbiol; 1995 Jul; 11(4):307-19. PubMed ID: 8541809 [TBL] [Abstract][Full Text] [Related]
12. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis. Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206 [TBL] [Abstract][Full Text] [Related]
13. Bacterial aggregation in relation to peritoneal dialysis. Reid G; Schwarz-Faulkner S; McGroarty JA; Bruce AW Perit Dial Int; 1990; 10(1):21-4. PubMed ID: 2085576 [TBL] [Abstract][Full Text] [Related]
14. Serological response to coagulase-negative staphylococci in patients with peritonitis on continuous ambulatory peritoneal dialysis. Dryden MS; Talsania H; Rodgers J; Bayston R; Phillips I Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):87-92. PubMed ID: 8500487 [TBL] [Abstract][Full Text] [Related]
15. Immunological defenses in CAPD. Lamperi S; Carozzi S Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal host defense mechanisms in peritoneal dialysis. Holmes CJ Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043 [No Abstract] [Full Text] [Related]
17. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium. Piraino B; Bernardini J; Holley JL; Perlmutter JA Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027 [TBL] [Abstract][Full Text] [Related]
18. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Cameron JS Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033 [TBL] [Abstract][Full Text] [Related]
19. Immunologic patterns in CAPD patients with peritonitis. Lamperi S; Carozzi S Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]